Kimberly Stegmaier, MD, Elected to National Academy of Medicine

BOSTON, MA [Oct. 20, 2026] - Kimberly Stegmaier, MD, Associate Chief, Division of Hematology/Oncology at Boston Children's Hospital, has been elected to the National Academy of Medicine. Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors.

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Dr. Stegmaier is among 100 individuals elected to the Academy in 2026.

Dr. Stegmaier is recognized for developing highly innovative methods for genetic and chemical genomic screens of cell phenotypes. She applied these successfully to understand pediatric cancer biology and discover drugs to treat specific cancers. This work prompted multiple drug discovery efforts in academia and industry and provides insight into oncogenic mechanisms underlying cancer.

In addition to her role as Associate Chief of the Division of Hematology/Oncology at Boston Children's, Dr. Stegmaier is also Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute; David G. Nathan Professor of Pediatrics, Harvard Medical School; and institute member, Broad Institute of Harvard and MIT, Boston.